Guangzhou Boji Medical and Biotechnological Co Ltd (300404) — Strategic Asset Allocation Index
Guangzhou Boji Medical and Biotechnological Co Ltd (300404) has a Strategic Asset Allocation Index of 35.1% as of June 2023. Strategic assets (PP&E of CN¥322.46 Million plus long-term investments of CN¥-) total CN¥322.46 Million, measured against net assets of CN¥918.92 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 300404 equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Guangzhou Boji Medical and Biotechnological Co Ltd Strategic Asset Allocation Index (2012–2021)
This chart shows how Guangzhou Boji Medical and Biotechnological Co Ltd's Strategic Asset Allocation Index has evolved across 10 annual periods from 2012 to 2021. As of June 2023, the index stands at 35.1%, representing strategic assets of CN¥322.46 Million against net assets of CN¥918.92 Million CNY. For live market cap and overall valuation, see market value of Guangzhou Boji Medical and Biotechnologi.
Annual Strategic Asset Allocation Index for Guangzhou Boji Medical and Biotechnological Co Ltd (2012–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Guangzhou Boji Medical and Biotechnological Co Ltd from 2012 to 2021, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is Guangzhou Boji Medical and Biotechnologi's book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 26.7% | CN¥225.78 Million | CN¥225.78 Million | CN¥- | CN¥846.38 Million | ▼ -11.6 pp |
| 2020 | 38.3% | CN¥185.86 Million | CN¥185.86 Million | CN¥- | CN¥485.00 Million | ▼ -6.5 pp |
| 2019 | 44.8% | CN¥204.52 Million | CN¥204.52 Million | CN¥- | CN¥456.08 Million | ▼ -10.1 pp |
| 2018 | 54.9% | CN¥232.66 Million | CN¥200.17 Million | CN¥32.50 Million | CN¥423.71 Million | ▲ +4.7 pp |
| 2017 | 50.2% | CN¥207.91 Million | CN¥190.39 Million | CN¥17.52 Million | CN¥414.35 Million | ▲ +13.1 pp |
| 2016 | 37.1% | CN¥159.37 Million | CN¥143.12 Million | CN¥16.25 Million | CN¥429.84 Million | ▲ +19.7 pp |
| 2015 | 17.4% | CN¥75.31 Million | CN¥68.81 Million | CN¥6.50 Million | CN¥432.68 Million | ▼ -11.2 pp |
| 2014 | 28.6% | CN¥62.57 Million | CN¥62.57 Million | CN¥- | CN¥218.48 Million | ▼ -1.6 pp |
| 2013 | 30.2% | CN¥62.11 Million | CN¥62.11 Million | CN¥- | CN¥205.52 Million | ▼ -4.7 pp |
| 2012 | 34.9% | CN¥59.47 Million | CN¥59.47 Million | CN¥- | CN¥170.36 Million | — |